Emerging Therapy Solutions

Private

Bloomington, MinnesotaHealthcare & Life Scienceshttps://emergingtherapies.com

Last Round

Series C

Mar 26, 2024

Total Funding Raised

$8M

Momentum Score

25 /100

Company Overview

Emerging Therapy Solutions is a healthcare company that provides risk and cost management services for payers dealing with high-cost cell, gene, and transplant therapies.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Healthcare Analytics, Compliance & Risk, Patient Engagement, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

cell and gene therapyCGTtransplant managementhealthcare cost containmentfinancial risk managementcarve-out solutionstop-loss insurancerisk forecastingspecialty therapy managementself-funded employerscare navigationclaims repricingpipeline monitoringvalue-based contractsPrograms of Excellencehealthcare point solution

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emerging Therapy Solutions Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Emerging Therapy Solutions Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Mar 26, 2024
Series B	Dec 20, 2022
VC Round	Jun 7, 2021
VC Round	Feb 11, 2021
VC Round	Feb 4, 2020
VC Round	May 8, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Jamison Rohde

Chief Operating Officer

Executive Team

Emerging Therapy Solutions Investors

Notable investors and investment history

Investor	Rounds
Telegraph Hill Partners	VC Round, Series B, Series C

View all Investors

Emerging Therapy Solutions Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Emerging Therapy Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Emerging Therapy Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersBloomington, Minnesota

Employee Range30

Year Founded2018

Last FundingMar 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.